Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase 3 1Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other 1

Conditions

Breast Neoplasms 4Polycystic Ovary Syndrome 1Pain 1Lung Neoplasms 1Insulin Resistance 1Fatigue 1Dyspnea 1Colorectal Neoplasms 1Anxiety Disorders 1

Interventions

Radiotherapy 39pembrolizumab 37Carboplatin 37Cisplatin 34Paclitaxel 26Pemetrexed 24Docetaxel 18Nivolumab 17Magnetic Resonance Spectroscopy 17Gemcitabine 17Bevacizumab 17Specimen Handling 16Cyclophosphamide 15osimertinib 14Radiation 13Irinotecan 13Etoposide 13Erlotinib Hydrochloride 12durvalumab 11Topotecan 10Cetuximab 10Radiosurgery 9Immunoglobulin G 8Fluorouracil 8Everolimus 8Disulfides 8Celecoxib 8fludarabine 7Taxes 7Ipilimumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Lung Neoplasms × Acupuncture Therapy × Clear all
NCT02094950 2019-07-23

Acupuncture Feasibility Trial for Dyspnea in Lung Cancer

Abramson Cancer Center at Penn Medicine

Phase 1 Completed
12 enrolled
OtherThoracic

Dyspnea, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡